Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px
All >

News > Northern Europe

Please find below news about Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden and the UK as well as about organisations from these countries.

Total search results: 5076 | Ordered by Date (descending)
1 2 3 ... 49 50 51  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Symphogen A/S. (4/3/20). "Press Release: Servier Signed a Definitive Agreement to Acquire Symphogen, a Leading Antibody Discovery Company, to Boost Its Antibody Capabilities and Leverage Its R&D Pipeline". Paris & Copenhagen. 2020-04-03
ERS Genomics Ltd.. (4/2/20). "Press Release: ERS Genomics and Axxam Announce CRISPR/Cas9 License Agreement to Enhance Discovery Services". Dublin & Milan. 2020-04-02
Actimed Therapeutics Ltd.. (4/2/20). "Press Release: Actimed Therapeutics Appoints Annalisa Jenkins as Advisor". London. 2020-04-02
ImaginAb, Inc.. (3/30/20). "Press Release: ImaginAb Announces Licensing Deal with AstraZeneca for CD8 ImmunoPET Technology". Los Angeles, CA. 2020-03-30
Owlstone Medical Ltd.. (3/30/20). "Press Release: Owlstone Medical Appoints Neil Tween as Chief Financial Officer". Cambridge. 2020-03-30
H. Lundbeck A/S. (3/27/20). "Press Release: Lundbeck Reports Headline Results from Phase IIa AMBLED study of Foliglurax in Parkinson’s Disease". Valby. 2020-03-27
Immune Regulation Ltd.. (3/27/20). "Press Release: Immune Regulation Ltd Appoints Jonathan Rigby as Chief Executive Officer". 2020-03-27
H. Lundbeck A/S. (3/27/20). "Press Release: Lundbeck Announces Phase IIa Study Results of Lu AG06466 in Adults with Tourette Syndrome". Valby. 2020-03-27
Bone Therapeutics S.A.. (3/26/20). "Press Release: Bone Therapeutics Appoints Stefanos Theoharis as Chief Business Officer". Gosselies. 2020-03-26
Randox Laboratories Ltd.. (3/26/20). "Press Release: Point of Care Coronavirus Test from Randox and Bosch Will Launch in April 2020". 2020-03-26
Evox Therapeutics Ltd.. (3/26/20). "Press Release: Evox Therapeutics and Takeda Sign Multi-target Rare Disease Collaboration". 2020-03-26
Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces Collaboration with AstraZeneca to Discover and Develop siRNA Therapeutics for Cardiovascular, Renal, Metabolic and Respiratory Diseases". London. 2020-03-25
Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces R&D Update". London. 2020-03-25
Bristol-Myers Squibb Company. (3/18/20). "Press Release: Bristol Myers Squibb Appoints Elizabeth Mily as Executive Vice President, Strategy & Business Development". New York, NY. 2020-03-18
Oxford BioMedica plc. (3/18/20). "Press Release: Building the Group for Future Growth. Business Update". Oxford. 2020-03-18
Oxford BioMedica plc. (3/18/20). "Press Release: Oxford BioMedica Signs License & Clinical Supply Agreement with Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, for LentiVector Platform for CAR-T and TCR-T Therapeutics". Oxford. 2020-03-18
Affimed N.V.. (3/17/20). "Press Release: Affimed Announces Appointment of Arndt Schottelius, M.D. Ph.D. as Chief Scientific Officer". Heidelberg. 2020-03-17
ImCheck Therapeutics S.A.S.. (3/17/20). "Press Release: ImCheck Therapeutics Expands Leadership Team with Appointment of Hans Henrik Chrois Christensen as Chief Financial Officer and Chief Operating Officer". Marseille. 2020-03-17
NeoPhore Ltd.. (3/17/20). "Press Release: NeoPhore Appoints Dr Matthew Baker as Chief Executive Officer". Cambridge. 2020-03-17
Tempus Labs, Inc.. (3/13/20). "Press Release: Tempus Announces $100 Million in Series G Financing". 2020-03-13
CureVac AG. (3/11/20). "Press Release: Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG". Tübingen & Boston, MA. 2020-03-11
MolMed S.p.A.. (3/9/20). "Press Release: The Board of Directors Approved the 2019 Full Year Financial Results". Milan. 2020-03-09
Genomics plc. (3/9/20). "Press Release: Mitchell Harris Joins Genomics plc as Chief Strategy Officer". Oxford. 2020-03-09
MolMed S.p.A.. (3/6/20). "Press Release: MolMed Signs a Multi-year Agreement and Announces the Beginning of a New Collaboration in the Field of T Cell Therapies". Milan. 2020-03-06
Alligator Bioscience AB. (3/5/20). "Press Release: Alligator Bioscience Appoints Andreas Johannesson as Interim Chief Financial Officer". Lund. 2020-03-05
CN Bio Innovations Ltd.. (3/2/20). "Press Release: CN Bio Innovations Raises $9 Million USD (c. £6.9 Million GBP)". Cambridge. 2020-03-02
Agilent Technologies Inc.. (3/2/20). "Press Release: Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions". Santa Clara, CA & Copenhagen. 2020-03-02
Immunocore Ltd.. (3/2/20). "Press Release: Immunocore Secures $130 Million Series B Financing". Oxfordshire & Conshohocken, PA. 2020-03-02
Evonetix Ltd.. (3/2/20). "Press Release: Evonetix Raises $30 Million USD (£23 Million GBP)". Cambridge. 2020-03-02
Cambridge Cancer Genomics Ltd.. (2/28/20). "Press Release: Precision-Panc and CCG.ai Partnership". Cambridge & Glasgow. 2020-02-28
Coulter Partners. (2/26/20). "Press Release: Coulter Partners Secures Chief Scientific Officer for Centogene". 2020-02-26
FinnGen. (2/25/20). "Press Release: FinnGen Welcomes Janssen and Maze Therapeutics". 2020-02-25
Bicycle Therapeutics plc. (2/25/20). "Press Release: Bicycle Therapeutics Announces Exclusive Strategic Collaboration with Genentech to Develop and Commercialize Bicycle-based Immuno-oncology Therapies". Cambridge & Boston, MA. 2020-02-25
Domainex Ltd.. (2/25/20). "Press Release: Lunac Therapeutics Selects Domainex as Its Strategic Drug Discovery Partner". Cambridge & Leeds. 2020-02-25
Yposkesi. (2/24/20). "Press Release: Yposkesi Welcomes Patrick Lansky as VP of US Sales & Marketing". Corbeil-Essonnes. 2020-02-24
DSM N.V.. (2/21/20). "Press Release: DSM to Acquire Glycom to Accelerate Growth in Early Life Nutrition". Heerlen. 2020-02-21
Immatics Biotechnologies GmbH. (2/20/20). "Press Release: Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies". Tübingen & Houston, TX. 2020-02-20
Scottish Enterprise. (2/17/20). "Press Release: Deputy First Minister Announces £9.5 Million to Compete in Global Precision Medicine Industry". 2020-02-17
PharmaMar S.A.. (2/17/20). "Press Release: PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer". Madrid & Dublin. 2020-02-17
Optibrium Ltd.. (2/17/20). "Press Release: Optibrium Appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development". Cambridge. 2020-02-17
Edinburgh Innovations. (2/17/20). "Press Release: Spinout Takes Aim at Treatments for Multiple Sclerosis". 2020-02-17
OMass Therapeutics Ltd.. (2/17/20). "Press Release: OMass Therapeutics Announces £27.5 Million Extended Series A Financing". Oxford. 2020-02-17
TrakCel Ltd.. (2/17/20). "Press Release: TrakCel Appoints Dr Fiona Withey as Chief Executive Officer". Cardiff. 2020-02-17
o2h Ventures. (2/15/20). "Press Release: o2h Ventures Makes an Investment in Pencil Biosciences, a Novel Gene Modulation Biotech". Cambridge. 2020-02-15
o2h Ventures. (2/15/20). "Press Release: o2h Ventures Is Pleased to Announce an Investment in Neurofenix, an Innovative Digital Health Company". Cambridge. 2020-02-15
o2h Ventures. (2/15/20). "Press Release: o2h Ventures Makes an Investment in Turbine". Cambridge. 2020-02-15
Domainex Ltd.. (2/13/20). "Press Release: Domainex Announces the Appointment of Tom Mander as Chief Executive Officer". Cambridge. 2020-02-13
Alligator Bioscience AB. (2/12/20). "Press Release: Alligator Bioscience AB Year-end Report January-December 2019". 2020-02-12
Freeline Therapeutics Ltd.. (2/12/20). "Press Release: Freeline Presents Data on Its AAV-based Gene Therapies for Fabry Disease and Gaucher Disease at the 16th annual WORLDSymposium". London. 2020-02-12
Lexington Communications. (2/12/20). "Press Release: Leading Strategy and Public Affairs Consultancy Opens New Office in Cambridge". 2020-02-12
ERS Genomics Ltd.. (2/11/20). "Press Release: ERS Genomics and Aelian Biotechnology Announce CRISPR/Cas9 License Agreement Enabling Aelian’s Unique Screening Platform". Dublin & Vienna. 2020-02-11
Nanoform Finland Ltd.. (2/10/20). "Press Release: Nanoform Establishes US Subsidiary". Helsinki. 2020-02-10
ERS Genomics Ltd.. (2/10/20). "Press Release: ERS Genomics Provides Comment on Affirmation of Key CRISPR-Cas9 Patent Involved in European Opposition Proceedings". Dublin. 2020-02-10
Orphazyme A/S. (2/7/20). "Press Release: Orphazyme Completes Offering of 7,032,937 Shares in a Directed Issue and Private Placement and Raises approximately DKK 745,000,000 (EUR 100 Million / USD 110 Million) [Not for US, CA, JP or AU]". Copenhagen. 2020-02-07
Freeline Therapeutics Ltd.. (2/4/20). "Press Release: Freeline Appoints Theresa Heggie as Chief Executive". London. 2020-02-04
MorphoSys AG. (2/4/20). "Press Release: MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S.". Planegg. 2020-02-04
Orion Corporation. (1/31/20). "Press Release: Positive CHMP Opinion for Darolutamide as a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer". 2020-01-31
Exscientia Ltd.. (1/30/20). "Press Release: Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Trial". 2020-01-30
Coulter Partners. (1/28/20). "Press Release: Coulter Partners Secures Chief Financial Officer for Stilla Technologies". 2020-01-28
Saga Diagnostics AB. (1/28/20). "Press Release: Saga Diagnostics Extends Its Collaboration with Servier to Use Ultrasensitive SAGAsafe Technology in Cancer Clinical Trials". Lund. 2020-01-28
Gilead Sciences, Inc.. (1/28/20). "Press Release: European Medicines Agency Validates Kite’s Marketing Application for Company’s Second CAR T Cell Therapy". Santa Monica, CA. 2020-01-28
Ervaxx Ltd.. (1/24/20). "Press Release: Ervaxx and Cardiff University Enter Collaboration to Develop novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens". London. 2020-01-24
PureTech Health plc. (1/23/20). "Press Release: PureTech Receives $200 Million from Sale of a Minority Portion of Affiliate Shares". 2020-01-23
Elypta AB. (1/23/20). "Press Release: Elypta Raises €6.1 Million in a Late Seed Round Led by Industrifonden". 2020-01-23
Orion Corporation. (1/23/20). "Press Release: Marketing Authorization Granted for Darolutamide in Japan". 2020-01-23
Oxford University Innovation. (1/23/20). "Press Release: Oxford Investment Opportunity Network and Oxford Angel Network Join Forces". 2020-01-23
Coulter Partners. (1/22/20). "Press Release: Coulter Partners Secures Chief Scientific Officer for OxStem". 2020-01-22
Blueprint Genetics Oy. (1/22/20). "Press Release: Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases". 2020-01-22
Qlucore AB. (1/21/20). "Press Release: Qlucore Moves into New Business Areas and Expands Board". 2020-01-21
Horizon Therapeutics plc. (1/21/20). "Press Release: FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)". Dublin. 2020-01-21
Exscientia Ltd.. (1/21/20). "Press Release: Exscientia Appoints Dr. David Hallett as Chief Operating Officer as Company Positions for Further Growth". 2020-01-21
Coulter Partners. (1/21/20). "Press Release: Coulter Partners Secures Head of US Sales for Nanoform". 2020-01-21
Clarivate Analytics plc. (1/17/20). "Press Release: Clarivate Analytics to Acquire Decision Resources Group, Creating a Leading Global Provider of Data-Driven Solutions to the Life Sciences Industry". London & Philadelphia, PA. 2020-01-17
ERS Genomics Ltd.. (1/17/20). "Press Release: ERS Genomics Provides Comment on EPO Technical Board of Appeal Decision Upholding Revocation of Broad Institute CRISPR Patent". Dublin. 2020-01-17
Charles River Laboratories International, Inc.. (1/16/20). "Press Release: Charles River Laboratories and Fios Genomics Form a Strategic Alliance to Provide Bioinformatics-driven Drug Discovery and Safety Assessment". Wilmington, MA & Edinburgh. 2020-01-16
Adaptimmune Therapeutics plc. (1/14/20). "Press Release: Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies". Tokyo, Philadelphia, PA & Oxfordshire. 2020-01-14
Vivoryon Therapeutics AG. (1/14/20). "Press Release: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration". Halle (Saale) & Herlev. 2020-01-14
ERS Genomics Ltd.. (1/13/20). "Press Release: ERS Genomics Licenses CRISPR Gene Editing Technology to Daiichi Sankyo to Support Internal Research and Development". Dublin. 2020-01-13
BioNTech SE. (1/13/20). "Press Release: BioNTech Appoints Ryan Richardson as Chief Strategy Officer to Support its Continued Global Expansion". Mainz. 2020-01-13
Bayer AG. (1/9/20). "Press Release: Bayer and Exscientia Collaborate to Leverage the Potential of Artificial Intelligence in Cardiovascular and Oncology Drug Discovery". Berlin. 2020-01-09
Grey Wolf Therapeutics Ltd.. (1/9/20). "Press Release: Grey Wolf Completes £2.5 Million Series A2 Financing for Development of Therapies Targeting ERAP2". Oxford. 2020-01-09
Alderaan Biotechnology S.A.S.. (1/9/20). "Press Release: Alderaan Biotechnology Raises €18.5m in Series A from Advent France Biotechnology (AFB) and Medicxi". Paris. 2020-01-09
Medicines Discovery Catapult, The. (1/9/20). "Press Release: Hearing Medicines Discovery Syndicate Launches to Fast-track the Development of Hearing Therapeutics". 2020-01-09
Avacta Group plc. (1/8/20). "Press Release: Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture". Cambridge & Seoul. 2020-01-08
GlaxoSmithKline plc. (1/8/20). "Press Release: Deborah Waterhouse, CEO of ViiV Healthcare, to Join GSK Corporate Executive Team (CET)". London. 2020-01-08
Galecto Biotech AB. (1/7/20). "Press Release: Galecto and PharmAkea Merge to Create Strong Clinical-stage Company Developing First-in-Class Therapeutics in Fibrosis and Cancer". San Diego, CA & Copenhagen. 2020-01-07
ERS Genomics Ltd.. (1/7/20). "Press Release: ERS Genomics Announces Agreement with New England Biolabs to Commercialize CRISPR Gene Editing Tools and Reagents". Dublin & Ipswich, MA. 2020-01-07
Bicycle Therapeutics plc. (1/7/20). "Press Release: Bicycle Therapeutics and Cancer Research UK to Collaborate on Development of New Bicycle Immuno-oncology Candidate, BT7401". London, Cambridge & Boston, MA. 2020-01-07
MiNA Therapeutics Ltd.. (1/7/20). "Press Release: MiNA Therapeutics Announces Research Collaboration with AstraZeneca in Metabolic Diseases". London. 2020-01-07
PhoreMost Ltd.. (1/7/20). "Press Release: PhoreMost and Boehringer Ingelheim Enter Multi-project Drug Discovery Collaboration". Cambridge. 2020-01-07
Novo Holdings A/S. (1/6/20). "Press Release: Novo Holdings REPAIR Impact Fund Invests USD 12 Million in Mutabilis and IBT Vaccines and Provides Strategic Update". Copenhagen. 2020-01-06
Nabriva Therapeutics plc. (12/20/19). "Press Release: Nabriva Therapeutics Resubmits New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin. 2019-12-20
Nabriva Therapeutics plc. (12/20/19). "Press Release: Nabriva Therapeutics Announces $20 Million Registered Direct Offering". Dublin & King of Prussia, PA. 2019-12-20
Zelluna Immunotherapy AS. (12/19/19). "Press Release: Zelluna Immunotherapy Appoints Namir Hassan as Chief Executive Officer". Oslo. 2019-12-19
Bone Therapeutics S.A.. (12/19/19). "Press Release: Bone Therapeutics Announces the Appointment of Dr. Miguel Forte as CEO to Lead the Company into the Next Phase of Development". Gosselies. 2019-12-19
Genmab A/S. (12/19/19). "Press Release: Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics". Copenhagen & Tübingen. 2019-12-19
Genomill Health. (12/18/19). "Press Release: Genomill Health Closes Investment Round to Expand Beta-testing with Liquid Biopsy Players". Turku. 2019-12-18
Pathios Therapeutics Ltd.. (12/18/19). "Press Release: Pathios Closes US$8.8m Series A and Appoints Stuart Hughes as CEO". Oxford. 2019-12-18
Alligator Bioscience AB. (12/17/19). "Press Release: First Patient Dosed with ATOR-1017 Developed for Metastasized Cancer". Lund. 2019-12-17
Edinburgh Molecular Imaging Ltd.. (12/17/19). "Press Release: Edinburgh Molecular Imaging Closes Financing". Edinburgh. 2019-12-17
1 2 3 ... 49 50 51  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px

» top